Hygrovest Limited (HGV.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.68 Million AUD | 3.75% |
| 2023 | 2.58 Million AUD | 29.14% |
| 2022 | 2 Million AUD | -39.6% |
| 2021 | 3.31 Million AUD | 141.82% |
| 2020 | 1.37 Million AUD | -86.33% |
| 2019 | 10.02 Million AUD | 677.5% |
| 2018 | 1.28 Million AUD | -75.99% |
| 2017 | 5.36 Million AUD | 12.42% |
| 2016 | 4.77 Million AUD | 2060.63% |
| 2015 | 221 Thousand AUD | 286.05% |
| 2014 | 57.24 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 141 Thousand AUD | -94.54% |
| 2024 Q2 | 2.46 Million AUD | 1646.81% |
| 2024 Q4 | 2.68 Million AUD | 0.0% |
| 2024 FY | 2.68 Million AUD | 3.75% |
| 2023 Q2 | 2.97 Million AUD | 1386.0% |
| 2023 Q4 | 2.58 Million AUD | 913.33% |
| 2023 FY | 2.58 Million AUD | 29.14% |
| 2023 Q3 | 255 Thousand AUD | -91.42% |
| 2023 Q1 | 200 Thousand AUD | -90.0% |
| 2022 Q4 | 2 Million AUD | 1415.91% |
| 2022 Q2 | 2.72 Million AUD | 1560.37% |
| 2022 FY | 2 Million AUD | -39.6% |
| 2022 Q1 | 164 Thousand AUD | -95.05% |
| 2022 Q3 | 132 Thousand AUD | -95.15% |
| 2021 Q1 | 128 Thousand AUD | -90.66% |
| 2021 FY | 3.31 Million AUD | 141.82% |
| 2021 Q4 | 3.31 Million AUD | 1328.02% |
| 2021 Q3 | 232 Thousand AUD | -91.54% |
| 2021 Q2 | 2.74 Million AUD | 2042.97% |
| 2020 FY | 1.37 Million AUD | -86.33% |
| 2020 Q1 | 6.06 Million AUD | -39.53% |
| 2020 Q2 | 8.62 Million AUD | 42.24% |
| 2020 Q4 | 1.37 Million AUD | 740.49% |
| 2020 Q3 | 163 Thousand AUD | -98.11% |
| 2019 FY | 10.02 Million AUD | 677.5% |
| 2019 Q2 | -12 Thousand AUD | 0.0% |
| 2019 Q3 | 6.43 Million AUD | 53725.0% |
| 2019 Q1 | -12 Thousand AUD | -100.93% |
| 2019 Q4 | 10.02 Million AUD | 55.74% |
| 2018 Q1 | 13.57 Million AUD | 152.89% |
| 2018 Q4 | 1.28 Million AUD | 230.51% |
| 2018 Q3 | 390 Thousand AUD | -97.13% |
| 2018 Q2 | 13.57 Million AUD | 0.0% |
| 2018 FY | 1.28 Million AUD | -75.99% |
| 2017 Q2 | 2.41 Million AUD | 0.0% |
| 2017 FY | 5.36 Million AUD | 12.42% |
| 2017 Q4 | 5.36 Million AUD | 71.83% |
| 2017 Q3 | 3.12 Million AUD | 29.2% |
| 2017 Q1 | 2.41 Million AUD | -49.36% |
| 2016 FY | 4.77 Million AUD | 2060.63% |
| 2016 Q1 | 4.73 Million AUD | 0.0% |
| 2016 Q4 | 4.77 Million AUD | -31.97% |
| 2016 Q3 | 7.01 Million AUD | 48.33% |
| 2016 Q2 | 4.73 Million AUD | 0.0% |
| 2015 FY | 221 Thousand AUD | 286.05% |
| 2015 Q2 | - AUD | -100.0% |
| 2015 Q1 | 57.24 Thousand AUD | 0.0% |
| 2014 FY | 57.24 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Althea Group Holdings Limited | 23.33 Million AUD | 88.512% |
| Cann Group Limited | 78.85 Million AUD | 96.6% |
| ECS Botanics Holdings Ltd | 4.66 Million AUD | 42.575% |
| Ecofibre Limited | 30.27 Million AUD | 91.146% |
| Elixinol Wellness Limited | 5.24 Million AUD | 48.924% |
| IDT Australia Limited | 7.93 Million AUD | 66.192% |
| Invion Limited | 1.01 Million AUD | -164.447% |
| Little Green Pharma Ltd | 16.39 Million AUD | 83.644% |
| Live Verdure Ltd | 1.95 Million AUD | -37.184% |
| Medical Developments International Limited | 13.42 Million AUD | 80.033% |
| Vitura Health Limited | 32.83 Million AUD | 91.836% |
| Vita Life Sciences Limited | 16.47 Million AUD | 83.728% |